Efficacy of pembrolizumab plus lenvatinib as first‐line treatment for metastatic renal cell carcinoma with multiple brain metastases

Introduction Patients with metastatic renal cell carcinoma have a poor prognosis and its specific pathogenesis remains unelucidated. Case presentation At 78 years of age, a Japanese male patient was diagnosed with metastatic renal cell carcinoma (cT3N2M1 stage) and multiple brain metastases that wer...

Descripció completa

Dades bibliogràfiques

Autors principals:	Daisuke Matsumoto, Taku Naiki, Aya Naiki‐Ito, Maria Aoki, Shinji Kato, Toshiharu Morikawa, Nobuhiko Shimizu, Masakazu Gonda, Yukihiro Umemoto, Takahiro Yasui
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-01-01
Col·lecció:	IJU Case Reports
Matèries:	brain neoplasms lenvatinib pembrolizumab radiosurgery renal cell carcinoma
Accés en línia:	https://doi.org/10.1002/iju5.12786
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!